IBDEI1KE ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25370,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,25370,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,25371,0)
 ;;=F03.90^^92^1150^18
 ;;^UTILITY(U,$J,358.3,25371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25371,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25371,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,25371,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,25372,0)
 ;;=G31.84^^92^1150^23
 ;;^UTILITY(U,$J,358.3,25372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25372,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,25372,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25372,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25373,0)
 ;;=F02.81^^92^1150^14
 ;;^UTILITY(U,$J,358.3,25373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25373,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,25373,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25373,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25374,0)
 ;;=F02.80^^92^1150^15
 ;;^UTILITY(U,$J,358.3,25374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25374,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/o Behav Dist
 ;;^UTILITY(U,$J,358.3,25374,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25374,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25375,0)
 ;;=A81.01^^92^1150^9
 ;;^UTILITY(U,$J,358.3,25375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25375,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,25375,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,25375,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,25376,0)
 ;;=F05.^^92^1150^13
 ;;^UTILITY(U,$J,358.3,25376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25376,1,3,0)
 ;;=3^Delirium d/t Physiological Cond
 ;;^UTILITY(U,$J,358.3,25376,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,25376,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,25377,0)
 ;;=R41.0^^92^1150^19
 ;;^UTILITY(U,$J,358.3,25377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25377,1,3,0)
 ;;=3^Disorientation,Unspec
 ;;^UTILITY(U,$J,358.3,25377,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,25377,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,25378,0)
 ;;=G31.09^^92^1150^20
 ;;^UTILITY(U,$J,358.3,25378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25378,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,25378,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,25378,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,25379,0)
 ;;=G90.3^^92^1150^24
 ;;^UTILITY(U,$J,358.3,25379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25379,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,25379,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,25379,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,25380,0)
 ;;=A81.9^^92^1150^28
 ;;^UTILITY(U,$J,358.3,25380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25380,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,25380,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,25380,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,25381,0)
 ;;=S06.2X9S^^92^1150^31
 ;;^UTILITY(U,$J,358.3,25381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25381,1,3,0)
 ;;=3^TBI,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,25381,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,25381,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,25382,0)
 ;;=R41.9^^92^1150^25
 ;;^UTILITY(U,$J,358.3,25382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25382,1,3,0)
 ;;=3^Neurocognitive D/O,Unspec
 ;;^UTILITY(U,$J,358.3,25382,1,4,0)
 ;;=4^R41.9
